Jefferies & Company Raises Dionex Corporation FY11 EPS To $3.70

Dionex Corporation's DNEX core focus in liquid chromatography analytical technologies, success in penetrating adjacent market niches, effective cost structure management, and disciplined capital re-deployment history have contributed to above-average organic revenue growth and profitability profiles and superior ROIC, Jefferies & Company reports. “DNEX's fiscal-1Q11 EPS of $0.62 fell $0.01 below consensus as an FX hedging loss (-$0.04) offset the effects of stronger revenue growth and a lower tax rate,” Jefferies & Company writes. “We are raising our FY11 EPS forecast to $3.70 (from $3.65).” Dionex Corporation currently trades at $92.83.